Krystal Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	9,110	7,197	4,511	3,503	2,041	1,763
Market Cap Growth	139.93%	59.55%	28.77%	71.63%	15.75%	49.07%
Enterprise Value	8,102	6,377	3,919	2,977	1,669	1,332
Last Close Price	309.03	246.54	156.66	124.06	79.22	69.95
PE Ratio	41.38	36.04	52.22	318.10	-	-
Forward PE	35.60	34.89	33.31	-	-	-
PS Ratio	21.83	18.50	15.53	69.09	-	-
PB Ratio	7.13	5.90	4.77	4.50	3.91	2.97
P/TBV Ratio	7.28	6.06	4.92	4.42	3.87	2.62
P/FCF Ratio	38.38	38.10	37.85	-	-	-
P/OCF Ratio	36.40	35.83	36.55	-	-	-
EV/Sales Ratio	19.42	16.39	13.49	58.73	-	-
EV/EBITDA Ratio	44.90	37.99	54.09	-	-	-
EV/EBIT Ratio	45.33	39.53	59.61	-	-	-
EV/FCF Ratio	34.13	33.75	32.89	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.01
Debt / EBITDA Ratio	0.05	0.06	0.10	-	-	-
Debt / FCF Ratio	0.04	0.05	0.06	-	-	-
Net Debt / Equity Ratio	-0.64	-0.67	-0.62	-0.67	-0.71	-0.72
Net Debt / EBITDA Ratio	-4.39	-4.88	-8.15	5.05	2.61	6.57
Net Debt / FCF Ratio	-3.43	-4.33	-4.95	5.21	2.41	3.70
Asset Turnover	0.31	0.33	0.31	0.07	0	0
Inventory Turnover	0.59	0.69	1.20	0.89	-	-
Quick Ratio	8.82	9.28	6.89	17.35	13.14	17.02
Current Ratio	9.46	9.95	7.28	17.76	13.30	17.18
Return on Equity (ROE)	18.03%	18.91%	10.34%	1.68%	-25.09%	-15.71%
Return on Assets (ROA)	14.20%	14.59%	6.56%	-13.50%	-24.51%	-14.57%
Return on Invested Capital (ROIC)	44.45%	45.74%	20.09%	-45.71%	-92.04%	-69.71%
Return on Capital Employed (ROCE)	14.18%	14.77%	7.56%	-16.67%	-25.69%	-15.24%
Earnings Yield	2.47%	2.77%	1.91%	0.31%	-	-
FCF Yield	2.61%	2.62%	2.64%	-	-	-
Buyback Yield / Dilution	-0.75%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%
Total Shareholder Return	-0.75%	-0.71%	-7.16%	-8.87%	-14.85%	-18.15%

SEC Filings: 10-K · 10-Q